Gold and Siver Ore Stocks – Dually Listed in the US and Canada – An Addition to The Top 25 for 2015
Number 14: RepliCel Life Sciences Inc.
(Symbol: REPCF)
Brief Description:RepliCel Life Sciences Inc. has developed RepliCel, a natural hair cell replication technology that has the potential to become the world’s first, minimally invasive solution for androgenetic alopecia (pattern baldness) and general hair loss in men and women. RepliCel is based on autologous cell implantation technology that replicates a patient’s hair cells from their own healthy hair follicles and, when reintroduced into areas of hair loss, the Company hopes to initiate natural hair regeneration. Patents for the technology have been issued by the European Union and Australia and are pending in other major international jurisdictions. The RepliCel procedure has been developed over the past nine years by the Company’s recognized research scientists and medical experts – specialists in the fields of hair growth, hair biology and dermatology. The address of the Company’s corporate office and principal place of business is Suite 1225 – 888 Dunsmuir Street, Vancouver, BC, V6C 3K4. |
Headquarters:RepliCel Life Sciences Inc.Suite 2020 – 401 West Georgia StreetVancouver, BCV6B 5A1Canada |
Web, Social, Email and Telephone Contact Info: (Shown where available)
Fax:
| Web: | http://www.replicel.com |
| Phone: | (604) 248-8697 |
| Facebook: | https://www.facebook.com/RepliCelLifeSciences?sk=app_208486042521740 |
| Twitter: | https://www.twitter.com/replicel |
| LinkedIn: | |
| Email: | [email protected] |
Click Next to See the Next Company!